TARGETING CDK4/6 IN HER2-POSITIVE BREAST CANCER BRAIN METASTASIS

$441,200FY2018Department of the ArmyDOD

Dana-Farber Cancer Institute, Inc.

Investigators

View source on USAspending →

TARGETING CDK4/6 IN HER2-POSITIVE BREAST CANCER BRAIN METASTASIS · GrantIndex